Pharmacokinetics and safety of GP2015, a proposed etanercept biosimilar, administered subcutaneously by an autoinjector or prefilled syringe in healthy male subjects

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2016
This article has no abstract
Epistemonikos ID: b70abecc69743ab77a5b9d95b9a0a6a111b42ea8
First added on: Feb 07, 2025